Precision BioSciences
DTIL
DTIL
119 hedge funds and large institutions have $93.5M invested in Precision BioSciences in 2022 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 33 increasing their positions, 30 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
21% less call options, than puts
Call options by funds: $15K | Put options by funds: $19K
22% less funds holding
Funds holding: 152 → 119 (-33)
50% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 56
Holders
119
Holding in Top 10
1
Calls
$15K
Puts
$19K
Top Buyers
| 1 | +$9.21M | |
| 2 | +$8.06M | |
| 3 | +$6.8M | |
| 4 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$4.25M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$3.97M |
Top Sellers
| 1 | -$3.5M | |
| 2 | -$2.1M | |
| 3 | -$1.74M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.56M |
| 5 |
Goldman Sachs
New York
|
-$1.3M |